Literature DB >> 19046568

The glucagon receptor is required for the adaptive metabolic response to fasting.

Christine Longuet1, Elaine M Sinclair, Adriano Maida, Laurie L Baggio, Marlena Maziarz, Maureen J Charron, Daniel J Drucker.   

Abstract

Glucagon receptor (Gcgr) signaling maintains hepatic glucose production during the fasting state; however, the importance of the Gcgr for lipid metabolism is unclear. We show here that fasted Gcgr-/- mice exhibit a significant increase in hepatic triglyceride secretion and fasting increases fatty acid oxidation (FAO) in wild-type (WT) but not in Gcgr-/- mice. Moreover fasting upregulated the expression of FAO-related hepatic mRNA transcripts in Gcgr+/+ but not in Gcgr-/- mice. Exogenous glucagon administration reduced plasma triglycerides in WT mice, inhibited TG synthesis and secretion, and stimulated FA beta oxidation in Gcgr+/+ hepatocytes. The actions of glucagon on TG synthesis and FAO were abolished in PPARalpha-/- hepatocytes. These findings demonstrate that the Gcgr receptor is required for control of lipid metabolism during the adaptive metabolic response to fasting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19046568      PMCID: PMC2593715          DOI: 10.1016/j.cmet.2008.09.008

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  43 in total

1.  Effects of exogenous glucagon on lipids in lipoproteins and liver of lactating dairy cows.

Authors:  G Bobe; B N Ametaj; J W Young; D C Beitz
Journal:  J Dairy Sci       Date:  2003-09       Impact factor: 4.034

2.  Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.

Authors:  Kyle W Sloop; Julia Xiao-Chun Cao; Angela M Siesky; Hong Yan Zhang; Diane M Bodenmiller; Amy L Cox; Steven J Jacobs; Julie S Moyers; Rebecca A Owens; Aaron D Showalter; Martin B Brenner; Achim Raap; Jesper Gromada; Brian R Berridge; David K B Monteith; Niels Porksen; Robert A McKay; Brett P Monia; Sanjay Bhanot; Lynnetta M Watts; M Dodson Michael
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

3.  CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-gamma.

Authors:  Stephan Herzig; Susan Hedrick; Ianessa Morantte; Seung-Hoi Koo; Francesco Galimi; Marc Montminy
Journal:  Nature       Date:  2003-11-13       Impact factor: 49.962

Review 4.  Factors affecting lipoprotein metabolism.

Authors:  A M Scanu
Journal:  Adv Lipid Res       Date:  1965

Review 5.  Glucagon physiology and pathophysiology.

Authors:  R H Unger
Journal:  N Engl J Med       Date:  1971-08-19       Impact factor: 91.245

6.  The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions.

Authors:  S Otway; D S Robinson
Journal:  J Physiol       Date:  1967-05       Impact factor: 5.182

7.  Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.

Authors:  Wasana K Sumanasekera; Eric S Tien; John W Davis; Rex Turpey; Gary H Perdew; John P Vanden Heuvel
Journal:  Biochemistry       Date:  2003-09-16       Impact factor: 3.162

8.  Hyperglucagonemia and its suppression. Importance in the metabolic control of diabetes.

Authors:  P Raskin; R H Unger
Journal:  N Engl J Med       Date:  1978-08-31       Impact factor: 91.245

9.  Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice.

Authors:  Yin Liang; Melville C Osborne; Brett P Monia; Sanjay Bhanot; William A Gaarde; Chantal Reed; Pengxiang She; Thomas L Jetton; Keith T Demarest
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

10.  Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist.

Authors:  D G Johnson; C U Goebel; V J Hruby; M D Bregman; D Trivedi
Journal:  Science       Date:  1982-02-26       Impact factor: 47.728

View more
  88 in total

1.  Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21.

Authors:  Holly A Cyphert; Xuemei Ge; Alison B Kohan; Lisa M Salati; Yanqiao Zhang; F Bradley Hillgartner
Journal:  J Biol Chem       Date:  2012-06-01       Impact factor: 5.157

Review 2.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

Authors:  Roger H Unger; Alan D Cherrington
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

3.  Novel approaches to treating type 2 diabetes.

Authors:  Michael A Nauck
Journal:  Diabetologia       Date:  2015-12-04       Impact factor: 10.122

4.  Structure of the glucagon receptor in complex with a glucagon analogue.

Authors:  Haonan Zhang; Anna Qiao; Linlin Yang; Ned Van Eps; Klaus S Frederiksen; Dehua Yang; Antao Dai; Xiaoqing Cai; Hui Zhang; Cuiying Yi; Can Cao; Lingli He; Huaiyu Yang; Jesper Lau; Oliver P Ernst; Michael A Hanson; Raymond C Stevens; Ming-Wei Wang; Steffen Reedtz-Runge; Hualiang Jiang; Qiang Zhao; Beili Wu
Journal:  Nature       Date:  2018-01-03       Impact factor: 49.962

5.  5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.

Authors:  Clinton M Hasenour; D Emerson Ridley; Curtis C Hughey; Freyja D James; E Patrick Donahue; Jane Shearer; Benoit Viollet; Marc Foretz; David H Wasserman
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

Review 6.  Distinct but complementary contributions of PPAR isotypes to energy homeostasis.

Authors:  Vanessa Dubois; Jérôme Eeckhoute; Philippe Lefebvre; Bart Staels
Journal:  J Clin Invest       Date:  2017-04-03       Impact factor: 14.808

7.  Treatment of Obese Insulin-Resistant Mice With an Allosteric MAPKAPK2/3 Inhibitor Lowers Blood Glucose and Improves Insulin Sensitivity.

Authors:  Lale Ozcan; Xiaoming Xu; Shi-Xian Deng; Devram S Ghorpade; Tiffany Thomas; Serge Cremers; Brian Hubbard; Michael H Serrano-Wu; Matthias Gaestel; Donald W Landry; Ira Tabas
Journal:  Diabetes       Date:  2015-06-11       Impact factor: 9.461

8.  The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice.

Authors:  J Hsieh; C Longuet; C L Baker; B Qin; L M Federico; D J Drucker; K Adeli
Journal:  Diabetologia       Date:  2009-12-03       Impact factor: 10.122

9.  OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin.

Authors:  Ligong Chen; Yan Shu; Xiaomin Liang; Eugene C Chen; Sook Wah Yee; Arik A Zur; Shuanglian Li; Lu Xu; Kayvan R Keshari; Michael J Lin; Huan-Chieh Chien; Youcai Zhang; Kari M Morrissey; Jason Liu; Jonathan Ostrem; Noah S Younger; John Kurhanewicz; Kevan M Shokat; Kaveh Ashrafi; Kathleen M Giacomini
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-24       Impact factor: 11.205

10.  Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice.

Authors:  Alessandro Pocai; Paul E Carrington; Jennifer R Adams; Michael Wright; George Eiermann; Lan Zhu; Xiaobing Du; Aleksandr Petrov; Michael E Lassman; Guoqiang Jiang; Franklin Liu; Corey Miller; Laurie M Tota; Gaochao Zhou; Xiaoping Zhang; Michael M Sountis; Alessia Santoprete; Elena Capito'; Gary G Chicchi; Nancy Thornberry; Elisabetta Bianchi; Antonello Pessi; Donald J Marsh; Ranabir SinhaRoy
Journal:  Diabetes       Date:  2009-07-14       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.